MDMX inhibits the p300/CBP-mediated acetylation of p53

Mdm2 promotes the rapid degradation of p53

Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · see citing works

Regulation of p53 stability by Mdm2

Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · see citing works

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · see citing works

hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase

Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,653 · see citing works

Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53

Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562 · see citing works

Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain

Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · see citing works

T antigen is bound to a host protein in SY40-transformed cells

Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,443 · see citing works

Negative Control of p53 by Sir2α Promotes Cell Survival under Stress

Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081 · see citing works

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951 · see citing works

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814 · see citing works

Atmospheric carbon dioxide concentrations over the past 60 million years

Pearson, P. N., & Palmer, M. R. (2000) · Nature · doi:10.1038/35021000 · Cited by 1,771 · see citing works

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,447 · see citing works

Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53

de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 1× · see citing works

DNA damage activates p53 through a phosphorylation–acetylation cascade

Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., & Appella, E. (1998) · Genes & Development · doi:10.1101/gad.12.18.2831 · Cited by 1,204 · see citing works

p300/CBP proteins: HATs for transcriptional bridges and scaffolds

Chan, H. M., & La Thangue, N. B. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.13.2363 · Cited by 1,092 · see citing works

The DNA-dependent protein kinasePreprint

Smith, G. C. M., & Jackson, S. P. (1999) · Genes & Development · doi:10.1101/gad.13.8.916 · Cited by 883 · see citing works

PML regulates p53 acetylation and premature senescence induced by oncogenic Ras

Pearson, M. A., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P., et al. (2000) · Nature · doi:10.1038/35018127 · Cited by 838 · see citing works

Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells

Sarnow, P., Ho, Y.-S., Williams, J., & Levine, A. J. (1982) · Cell · doi:10.1016/0092-8674(82)90356-7 · Cited by 836 · see citing works

Deacetylation of p53 modulates its effect on cell growth and apoptosis

Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. J. (2000) · Nature · doi:10.1038/35042612 · Cited by 818 · see citing works

p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage

Liu, L., Scolnick, D. M., Trievel, R. C., Zhang, H. B., Marmorstein, R., Halazonetis, T. D., & Berger, S. L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1202 · Cited by 776 · see citing works

Binding and modulation of p53 by p300/CBP coactivators

Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J. A., & Livingston, D. M. (1997) · Nature · doi:10.1038/42981 · Cited by 693 · see citing works

Structure and Function of the p53 Tumor Suppressor Gene: Clues for Rational Cancer Therapeutic Strategies

Harris, C. C. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1442 · Cited by 682 · see citing works

Recruitment of p300/CBP in p53-Dependent Signal Pathways

Avantaggiati, M. L., Ogryzko, V. V., Gardner, K., Giordano, A., Levine, A. S., & Kelly, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80304-9 · Cited by 668 · see citing works

Twenty years of p53 research: structural and functional aspects of the p53 protein

May, P., & May, E. (1999) · Oncogene · doi:10.1038/sj.onc.1203285 · Cited by 663 · see citing works

MDMX: a novel p53‐binding protein with some functional properties of MDM2.

Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00919.x · Cited by 648 · see citing works

Synergistic activation of transcription by CBP and p53

Gu, W., Shi, X.-L., & Roeder, R. G. (1997) · Nature · doi:10.1038/42972 · Cited by 596 · see citing works

p300/CBP‐mediated p53 acetylation is commonly induced by p53‐activating agents and inhibited by MDM2

Ito, A., Lai, C.-H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., & Yao, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1331 · Cited by 582 · see citing works

Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53

Parant, J., Chavez-Reyes, A., Little, N. A., Yan, W., Reinke, V., Jochemsen, A. G., & Lozano, G. (2001) · Nature Genetics · doi:10.1038/ng714 · Cited by 517 · see citing works

Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2

Dumaz, N., & Meek, D. W. (1999) · The EMBO Journal · doi:10.1093/emboj/18.24.7002 · Cited by 455 · see citing works

Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBPPreprint

Kung, A. L., Rebel, V. I., Bronson, R. T., Ch'ng, L.-E., Sieff, C. A., Livingston, D. M., & Yao, T. (2000) · Genes & Development · doi:10.1101/gad.14.3.272 · Cited by 442 · see citing works

The E6 protein of human papillomavirus type 16 binds to and inhibits co‐activation by CBP and p300

Patel, D., Huang, S., Baglia, L. A., & McCance, D. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5061 · Cited by 429 · see citing works

Phosphorylation of p53 Serine 15 Increases Interaction with CBP

Lambert, P. F., Kashanchi, F., Radonovich, M. F., Shiekhattar, R., & Brady, J. N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.33048 · Cited by 423 · see citing works

p300/MDM2 complexes participate in MDM2-mediated p53 degradation

Grossman, S. R., Perez, M., Kung, A. L., Joseph, M., Mansur, C., Xiao, Z.-X., Kumar, S., Howley, P. M., & Livingston, D. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80140-9 · Cited by 414 · see citing works

Regulation of Histone Acetyltransferases p300 and PCAF by the bHLH Protein Twist and Adenoviral Oncoprotein E1A

Hamamori, Y., Sartorelli, V., Ogryzko, V., Puri, P. L., Wu, H.-Y., Wang, J. Y. J., Nakatani, Y., & Kedes, L. (1999) · Cell · doi:10.1016/s0092-8674(00)80553-x · Cited by 368 · see citing works

A Viral Mechanism for Inhibition of p300 and PCAF Acetyltransferase Activity

Chakravarti, D., Ogryzko, V., Kao, H.-Y., Nash, A., Chen, H., Nakatani, Y., & Evans, R. M. (1999) · Cell · doi:10.1016/s0092-8674(00)80552-8 · Cited by 339 · see citing works

Regulation of p53 Function

Woods, D. B., & Vousden, K. H. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5141 · Cited by 318 · see citing works

Stabilization of the MDM2 Oncoprotein by Interaction with the Structurally Related MDMX Protein

Sharp, D. A., Kratowicz, S. A., Sank, M. J., & George, D. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38189 · Cited by 286 · see citing works

p300 gene alterations in colorectal and gastric carcinomas.

Muraoka, M., Konishi, M., Kikuchi‐Yanoshita, R., Tanaka, K., Shitara, N., Chong, J., Iwama∥, T., & Miyaki, M. (1996) · PubMed · Cited by 282 · see citing works

Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification.

Riemenschneider, M. J., Büschges, R., Wolter, M., REIFENBERGER, J., Boström, J. P., Kraus, J. A., Schlegel, U. S., & Reifenberger, G. (1999) · PubMed · Cited by 247 · see citing works

Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms

Stad, R., Little, N. A., Xirodimas, D. P., Frenk, R., van der Eb, A. J., Lane, D. P., Saville, M. K., & Jochemsen, A. G. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve227 · Cited by 234 · see citing works

MdmX Protects p53 from Mdm2-Mediated Degradation

Jackson, M. W., & Berberich, S. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.1001-1007.2000 · Cited by 211 · cited 7× · see citing works

MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins

Kobet, E., Zeng, X., Zhu, Y., Keller, D., & Lu, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12547 · Cited by 193 · see citing works

Comparative study of the p53-mdm2 and p53-MDMX interfaces

Böttger, V., Böttger, A., Garcia-Echeverria, C., Ramos, Y. F., van der Eb, A. J., Jochemsen, A. G., & Lane, D. P. (1999) · Oncogene · doi:10.1038/sj.onc.1202281 · Cited by 189 · see citing works

CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein.

Scolnick, D. M., Chehab, N. H., Stavridi, E. S., Lien, M. C., Caruso, L. C., Morán, E., Berger, S. L., & Halazonetis, T. D. (1997) · PubMed · Cited by 186 · see citing works

Hdmx Stabilizes Mdm2 and p53

Stad, R., Ramos, Y. F. M., Little, N., Grivell, S., Attema, J., van der Eb, A. J., & Jochemsen, A. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003496200 · Cited by 145 · see citing works

Cell Cycle Regulation of the Transcriptional Coactivators p300 and CREB Binding Protein

Snowden, A. W., & Perkins, N. D. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00020-3 · Cited by 68 · see citing works

The Role of P53 in Human Cancer

Malkin, D. M. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010636426860 · Cited by 52 · see citing works

Tumor p53 status and response to topoisomerase II inhibitors

Valkov, N. I., & Sullivan, D. M. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00143-7 · Cited by 35 · see citing works

Constitutive mdmx Expression During Cell Growth, Differentiation, and DNA Damage

Jackson, M. W., & Berberich, S. J. (1999) · DNA and Cell Biology · doi:10.1089/104454999314971 · Cited by 27 · see citing works

p53 ubiquitination: Mdm2 and beyond

Brooks, C. L., & Gu, W. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.020 · Cited by 924 · see citing works

The p53 orchestra: Mdm2 and Mdmx set the tone

Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450 · see citing works

p53 Acetylation: Regulation and Consequences

Reed, S. M., & Quelle, D. E. (2014) · Cancers · doi:10.3390/cancers7010030 · Cited by 330 · see citing works

Amplification of <i>Mdmx</i> (or <i>Mdm4</i> ) Directly Contributes to Tumor Formation by Inhibiting p53 Tumor Suppressor Activity

Danovi, D., Meulmeester, E., Pasini, D., Migliorini, D., Capra, M., Frenk, R., de Graaf, P., Francoz, S., Gasparini, P., Gobbi, A., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5835-5843.2004 · Cited by 310 · see citing works

MDMX: from bench to bedside

Marine, J.-C. W., Dyer, M. A., & Jochemsen, A. G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03362 · Cited by 228 · see citing works

Mdmx as an essential regulator of p53 activity

Marine, J., & Jochemsen, A. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.151 · Cited by 186 · see citing works

Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage

Pereg, Y., Shkedy, D., de Graaf, P., Meulmeester, E., Edelson-Averbukh, M., Salek, M., Biton, S., Teunisse, A. F. A. S., Lehmann, W. D., Jochemsen, A. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408595102 · Cited by 181 · see citing works

The Transactivation Domains of the p53 ProteinPreprint

Raj, N., & Attardi, L. D. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026047 · Cited by 174 · see citing works

JMJD6 Promotes Colon Carcinogenesis through Negative Regulation of p53 by Hydroxylation

Wang, F., He, L., Huangyang, P., Liang, J., Si, W., Yan, R., Han, X., Liu, S., Gui, B., Li, W., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001819 · Cited by 144 · see citing works

Regulation of p53: a collaboration between Mdm2 and MdmX

Pei, D., Zhang, Y., & Zheng, J. (2012) · Oncotarget · doi:10.18632/oncotarget.443 · Cited by 140 · see citing works

β-Arrestin 2 Functions as a G-Protein-coupled Receptor-activated Regulator of Oncoprotein Mdm2

Wang, P., Gao, H., Ni, Y., Wang, B., Wu, Y., Ji, L., Qin, L.-H., Ma, L., & Pei, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210350200 · Cited by 134 · see citing works

DNA Damage-Induced Phosphorylation of MdmX at Serine 367 Activates p53 by Targeting MdmX for Mdm2-Dependent Degradation

Okamoto, K., Kashima, K., Pereg, Y., Ishida, M., Yamazaki, S., Nota, A., Teunisse, A., Migliorini, D., Kitabayashi, I., Marine, J.-C., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9608-9620.2005 · Cited by 129 · see citing works

MDM2 and MDMX: Alone and together in regulation of p53.

Shadfan, M., Lopez-Pajares, V., & Yuan, Z.-M. (2012) · PubMed · Cited by 125 · see citing works

Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?Preprint

da Costa, D. C. F., de Oliveira, G. A. P., Cino, E. A., Soares, I. N., Rangel, L. P., & Silva, J. L. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023614 · Cited by 89 · see citing works

MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and BeyondPreprint

Marine, J., & Jochemsen, A. G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026237 · Cited by 81 · see citing works

Human tumor suppressor p53 and DNA viruses

Collot-Teixeira, S., Bass, J., Denis, F., & Ranger‐Rogez, S. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.431 · Cited by 67 · see citing works

The MDM4/MDM2-p53-IGF1 axis controls axonal regeneration, sprouting and functional recovery after CNS injury

Joshi, Y., Sória, M. G., Quadrato, G., Inak, G., Zhou, L., Hervera, A., Rathore, K. I., Elnaggar, M., Cucchiarini, M., Marine, J., et al. (2015) · Brain · doi:10.1093/brain/awv125 · Cited by 65 · see citing works

C-Abl as a modulator of p53

Levav-Cohen, Y., Goldberg, Z., Zuckerman, V., Grossman, T., Haupt, S., & Haupt, Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.152 · Cited by 55 · see citing works

Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer

de Oliveira, G. A. P., Rangel, L. P., da Costa, D. C. F., & Silva, J. L. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00097 · Cited by 55 · see citing works

Insights into regulators of p53 acetylation

Nagasaka, M., Miyajima, C., Aoki, H., Aoyama, M., Morishita, D., Inoue, Y., & Hayashi, H. (2022) · Cells · doi:10.3390/cells11233825 · Cited by 45 · see citing works

Targeting mechanosensitive MDM4 promotes lung fibrosis resolution in aged mice

Qu, J., Yang, S., Zhu, Y., Guo, T., Thannickal, V. J., & Zhou, Y. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202033 · Cited by 43 · see citing works

Anatomy of Mdm2 and Mdm4 in evolution

Tan, B. X., Liew, H. P., Chua, J. S., Ghadessy, F. J., Tan, Y. S., Lane, D. P., & Coffill, C. R. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx002 · Cited by 40 · see citing works

MDM4 (MDMX) and its Transcript Variants

Mancini, F., Conza, G. D., & Moretti, F. (2009) · Current Genomics · doi:10.2174/138920209787581280 · Cited by 39 · see citing works

Potential therapeutic targets ofTP53gene in the context of its classically canonical functions and its latest non-canonical functions in human cancer

Tanaka, T., Watanabe, M., & Yamashita, K. (2018) · Oncotarget · doi:10.18632/oncotarget.24611 · Cited by 39 · see citing works

MDM4 (MDMX) Overexpression Enhances Stabilization of Stress-induced p53 and Promotes Apoptosis

Mancini, F., Gentiletti, F., D'Angelo, M., Giglio, S., Nanni, S., D’Angelo, C., Farsetti, A., Citro, G., Sacchi, A., Pontecorvi, A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311793200 · Cited by 38 · see citing works

MDM2 and MDMX in Cancer and Development

Marine, J. (2011) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00003-6 · Cited by 38 · see citing works

Functions of MDMX in the Modulation of the p53‐Response

Lenos, K., & Jochemsen, A. G. (2011) · BioMed Research International · doi:10.1155/2011/876173 · Cited by 38 · see citing works

CARPs enhance p53 turnover by degrading 14-3-3σ and stabilizing MDM2

Yang, W., Dicker, D. T., Chen, J., & El‐Deiry, W. S. (2008) · Cell Cycle · doi:10.4161/cc.7.5.5701 · Cited by 36 · see citing works

Tumor p53 status and response to topoisomerase II inhibitors

Valkov, N. I., & Sullivan, D. M. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00143-7 · Cited by 35 · see citing works

Mathematical modelling of p53 basal dynamics and DNA damage response

Chong, K. H., Samarasinghe, S., & Kulasiri, D. (2014) · Mathematical Biosciences · doi:10.1016/j.mbs.2014.10.010 · Cited by 31 · see citing works

p73: From the p53 shadow to a major pharmacological target in anticancer therapy

Ramos, H., Raimundo, L., & Saraiva, L. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105245 · Cited by 31 · see citing works

Deregulation of cyclin E meets dysfunction in p53: Closing the escape hatch on breast cancer

Barton, M. C., Akli, S., & Keyomarsi, K. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20818 · Cited by 28 · see citing works

Regulation of MDM4

Markey, M. P. (2010) · Frontiers in bioscience · doi:10.2741/3780 · Cited by 24 · see citing works

Phosphorylation of MdmX by CDK2/Cdc2p34 is required for nuclear export of Mdm2

Elias, B. C., Laine, A. M., & Ronai, Z. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208488 · Cited by 24 · see citing works

Telomere attrition induces a DNA double-strand break damage signal that reactivates p53 transcription in HTLV-I leukemic cells

Datta, A., & Nicot, C. (2007) · Oncogene · doi:10.1038/sj.onc.1210718 · Cited by 23 · see citing works

Drug-dependent functionalization of wild-type and mutant p53 in cisplatin-resistant human ovarian tumor cells

Bhatt, M., Ivan, C., Xie, X., & Siddik, Z. H. (2016) · Oncotarget · doi:10.18632/oncotarget.14228 · Cited by 23 · see citing works

Regulation of p53-dependent transcription

Jõers, A. (2004) · DSpace repository (University of Tartu) · Cited by 20 · see citing works

Mdm2 RING Mutation Enhances p53 Transcriptional Activity and p53-p300 Interaction

Clegg, H. V., Itahana, Y., Itahana, K., Ramalingam, S., & Zhang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038212 · Cited by 15 · see citing works

Functional Activation of Mutant p53 by Platinum Analogues in Cisplatin-Resistant Cells Is Dependent on Phosphorylation

Xie, X., He, G., & Siddik, Z. H. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0257-t · Cited by 14 · see citing works

Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia

Abramowitz, J., Neuman, T., Perlman, R., & Ben‐Yehuda, D. (2017) · BMC Medical Genomics · doi:10.1186/s12920-017-0249-2 · Cited by 14 · see citing works

Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice

Tian, H., Tackmann, N. R., Jin, A., Zheng, J., & Zhang, Y. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000122 · Cited by 9 · see citing works

MDMX is essential for the regulation of p53 protein levels in the absence of a functional MDM2 C-terminal tail

Sanford, J. D., Yang, J., Han, J., Tollini, L. A., Jin, A., & Zhang, Y. (2021) · BMC Molecular and Cell Biology · doi:10.1186/s12860-021-00385-3 · Cited by 7 · see citing works

HDM2 and HDMX Proteins in Human Cancer

Hároníková, L., & Vojtěšek, B. (2018) · Klinicka onkologie · doi:10.14735/amko20182s63 · Cited by 4 · see citing works

Cooperation between MDM2 and MDMX in the Regulation of p53

Blaydes, J. P. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_6 · Cited by 2 · see citing works

Set the Tone:

(2018) · Yale University Press eBooks · doi:10.2307/j.ctvqc6gvg.12 · Cited by 2 · see citing works

Transcriptional Activation by p53: Mechanisms and Targeted Genes

MacLachlan, T. K., & El‐Deiry, W. S. (2007) · Springer eBooks · doi:10.1007/0-387-30127-5_3 · Cited by 1 · see citing works

Tumor suppressor p53 and transcriptional changes in cellular stress responses to UV radiation

Latonen, L. (2003) · Työväentutkimus Vuosikirja

Mathematical modelling of the core regulatory feedback mechanisms of p53 protein that decide cell fate

Chong, K. H. (2014) · Lincoln University Research Archive (Lincoln University)

Multiple modes of Mdmx regulation affect p53 activation

Gilkes, D. M. (2008) · Digital Commons - University of South Florida (University of South Florida)

Modulation of p53 activities by the prolyl-isomerase PIN1 and the bromodomain protein BRD7

Tocco, F. (2008) · OpenstarTs (Univeristy of Trieste https://www.units.it/)

Molecular mechanisms of growth suppression by pharmacologically activated p53

Hedström, E. (2009) · Figshare

Analysis of p53 and c-MYC, two key transcription factors involved in tumorigenesis

Jung, P. (2008) · doi:10.5282/edoc.10559

Modeling of ATM Accumulation and ATM-Mediated Oscillation of p53

Guo, Z.-G., Tong-Jun, Z., Yuan, C., Liu, H., Yang, Y., Yu, K., Zeng, L.-B., & Zhan, Y. (2009) · International Conference on Bioinformatics and Biomedical Engineering · doi:10.1109/icbbe.2009.5163075

p53 and DNA damage checkpoint responses in the human prostate

af Hällström, T. (2007)

Exploring Chromatin-bound MDM2 Functions in Compromised Transcriptional Regulation of p53 Target Genes

Rosso, M. (2015) · CUNY Academic Works (City University of New York)

Activation of the p53 Tumor Suppressor and its Multiple Roles in Cell Cycle and Apoptosis

Giono, L. E., & Manfredi, J. J. (2009) · Springer eBooks · doi:10.1007/978-3-642-02112-1_20

An investigation of mutant p53 function.

Noll, J. E. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)

Characterization of NEK10 Tyrosine Kinase Activity in the Cellular Response to DNA Damage

Haider, N. (2018) · TSpace (University of Toronto)

Characterization of consecutive p53 responses separated by a period of recovery in human cells and samples from acute myeloid leukemia patients undergoing allogenic stem cell transplantation

Chmara, J. (2016) · doi:10.22215/etd/2016-11527

Hdm2 disrupts HdmX-mediated nuclear export of p53 by sequestering it in nucleus

Ni, Y., Chen, H., Cheng, X., Sun, B., Wu, Z., Zhan, Q., & Zhuang, Z. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114185

Additional file 1 of MDMX is essential for the regulation of p53 protein levels in the absence of a functional MDM2 C-terminal tail

Sanford, J. D., Yang, J., Han, J., Tollini, L. A., Jin, A., & Zhang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16664347

MDM4 at the Crossroads: Beyond p53 and MDM2

Thapa, D., John, A. S., Parrales, A., Ranjan, A., & Iwakuma, T. (2026) · Cancers · doi:10.3390/cancers18071059

p300/CBP‐mediated p53 acetylation is commonly induced by p53‐activating agents and inhibited by MDM2

Ito, A., Lai, C.-H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., & Yao, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1331 · Cited by 582 · see citing works

MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins

Kobet, E., Zeng, X., Zhu, Y., Keller, D., & Lu, H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12547 · Cited by 193 · see citing works

MDM2 Inhibits PCAF (p300/CREB-binding Protein-associated Factor)-mediated p53 Acetylation

Jin, Y., Zeng, S. X., Dai, M., Yang, X., & Lu, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204078200 · Cited by 86 · see citing works

Inhibition of p53 degradation by Mdm2 acetylation

Wang, X., Taplick, J., Geva, N., & Oren, M. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00168-1 · Cited by 108 · see citing works

MDM2–HDAC1-mediated deacetylation of p53 is required for its degradation

Ito, A., Kawaguchi, Y., Lai, C., Kovacs, J. J., Higashimoto, Y., Appella, E., & Yao, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf616 · Cited by 570 · see citing works